期刊文献+

鼠p53 172位点不同结构的minigene四环素负调控表达模式对肺癌细胞体外生长的影响 被引量:2

Effect of mouse p53 minigene on lung cancer cells with different 172 structures regulated by tetracycline
原文传递
导出
摘要 目的 利用四环素负调控表达载体诱导表达鼠野生型p5 3、假野生突变型p5 3和突变型p5 3(172位点氨基酸分别是精氨酸、亮氨酸和组氨酸 ) ,比较一个位点不同DNA结构的p5 3minigene对细胞生长的影响。方法 通过基因重组构建四环素负调控表达的小鼠上述 3种p5 3minigene真核表达载体 ,由LipofectAMINE介导转染p5 3突变的PG细胞 ,嘌呤霉素筛选得到稳定克隆 ,利用四甲基偶氮唑盐比色法、流式细胞术、蛋白质免疫印迹等方法比较 3种p5 3对细胞体外生长的影响。结果 野生型和假野生突变型p5 3可以导致细胞生长变慢、细胞周期阻滞、p2 1表达增高 ,突变型则无以上效应。结论 野生型和假野生突变型p5 3具有抑制细胞生长引起周期阻滞的功能 ,突变型p5 3则丧失了野生型p5 3的抑瘤功能 ;p5 3基因的某些突变 (如鼠 172位点精氨酸→亮氨酸 ) Objective To investigate the effect of mouse 172 wild type p53(Arg), pseudo wild mutant type p53(Arg→Leu) and mutant type p53(Arg→His) induced by absence of tetracycline on the growth of PG cell line. Methods Three variant types of p53 minigene were sub cloned by gene recombination into an expression vector which was controlled by tetracycline. Through LipofectAMINE, the vectors were transfected into p53 defective PG(248CGG→CTT) cells, and the transfectants were screened in the selecting medium containing puromycin. Tumor suppressing effects were studied by MTT absorption, flow cytometry and Western blotting. Results Wild type p53 and pseudo wild mutant type p53 could lead cells to decrease their growth rates, arrest cell cycle and transactivation of p21 WAF1 . Mutant type p53 was defective in tumor suppression. Conclusion Wild type p53 and pseudo wild type p53 may inhibit cell growth and induce cell cycle arrest. Some p53 variants such as 172 Arg→Leu can still retain the tumor suppression function of the wild type.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2000年第5期359-362,共4页 Chinese Journal of Pathology
关键词 肺肿瘤 四环素 负调控 p^53minigene Genes p53 Lung neoplasms Tumor cells cultured Gene expression regulation
  • 相关文献

参考文献5

二级参考文献14

  • 1张波 崔文.人高转移肺癌细胞系p53基因突变的研究[J].中华肿瘤杂志,1996,13:655-657.
  • 2吴秉铨 孙毓恺 等.裸鼠体内建立的人类高转移癌[J].中华肿瘤杂志,1985,7:324-327.
  • 3Li B,Cell Growth Differ,1994年,5期,711页
  • 4吴秉铨,中华肿瘤杂志,1985年,7卷,324页
  • 5张波,中华肿瘤杂志,1996年,13卷,655页
  • 6Li B,Mol Carcinog,1995年,14卷,75页
  • 7顾健人,中华医学杂志,1997年,77卷,723页
  • 8孙梅,中国肿瘤生物治疗杂志,1996年,3卷,11页
  • 9张波,中华肿瘤杂志,1996年,13卷,655页
  • 10Li B,Mol Carcinog,1995年,14卷,75页

共引文献5

同被引文献29

  • 1许少峰,付丽.p53研究的新进展[J].中华病理学杂志,2004,33(6):559-561. 被引量:24
  • 2李玲,张波,邹万忠,郑杰.端粒重复因子2与p53的体外结合[J].中华病理学杂志,2005,34(2):88-91. 被引量:1
  • 3高崇峰,吕有勇.胃癌组织中多种癌基因变异的观察[J].中华医学杂志,1996,76(9):671-675. 被引量:10
  • 4Yu W,Pirollo KF,Rait A,et al.A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene.Gene Therapy,2004,11:1434-1440.
  • 5Liu Q,Gazitt Y.Potentiation of dexamethasone-,paclitaxel-,and Ad-p53-induced apoptosis byBcl-2 antisense oligodeoxynucleotides in drug-resistant multiple myeloma cells.Blood,2003,101:4105-4114.
  • 6Martinez LA,Naguibneva I,Lehrmann H,et al.Synthetic small inhibiting RNAs:efficient tools to inactivate oncogenic mutations and restore p53 pathways.Proc Natl Acad Sci U S A,2002,99:14849-14854.
  • 7Shin KS,Sullenger BA,Lee SW.Ribozyme-midiated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA.Mol Ther,2004,10:365-372.
  • 8Watanabe T,Sullenger BA.Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts.Proc Natl Acad Sci U S A,2000,97:8490-8494.
  • 9Issaeva N,Friedler A,Bozko P,et al.Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide.Proc Natl Acad Sci U S A,2003,100:13303-13307.
  • 10Baroni TE,Wang T,Qian H,et al.A global suppressor motif for p53 cancer mutants.Proc Natl Acad Sci U S A,2004,101:4930-4935.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部